Texas Attorney General Sues Tylenol Manufacturers Over Alleged Autism Risks

Texas Attorney General Ken Paxton has initiated legal action against Johnson & Johnson and its spinoff company, Kenvue, alleging that they deceptively marketed Tylenol to pregnant women while concealing potential risks of autism in unborn children. The lawsuit claims that the companies were aware that acetaminophen, Tylenol's active ingredient, could lead to a significantly increased risk of autism and other disorders, yet continued to promote the product as safe during pregnancy.

"Big Pharma betrayed America by profiting off of pain and pushing pills regardless of the risks," Paxton stated.

In response, Kenvue issued a statement expressing concern over the spread of misinformation regarding acetaminophen's safety and emphasized the potential health impact on American women and children. The company asserted its commitment to defending against these claims, highlighting the global medical community's recognition of acetaminophen's safety when used appropriately during pregnancy.

Medical experts have noted that while some studies suggest a possible association between acetaminophen use during pregnancy and developmental disorders, the evidence is not conclusive. The U.S. Food and Drug Administration (FDA) maintains that acetaminophen is the safest over-the-counter pain reliever for pregnant women when used as directed.

This lawsuit follows recent statements by President Donald Trump, who, alongside Health and Human Services Secretary Robert F. Kennedy Jr., suggested a link between Tylenol use during pregnancy and an increased risk of autism. These claims have been met with skepticism from the medical community, which emphasizes the lack of definitive evidence supporting such assertions.